Previous 10 | Next 10 |
Gainers: Aditxt ADTX +76%, BioLife Solutions (NASDAQ:BLFS) +15%, Virpax Pharmaceuticals (NASDAQ:VRPX) +10%, Flexion Therapeutics FLXN +9%, Rafael (NYSE:RFL) +7%. Losers: Cassava Sciences SAVA -22%, 111 (NASDAQ:YI) -15%, Owlet (NYSE:OWLT) ...
The company enjoys strong secular tailwinds from a growing regenerative medicine market, gaining lots of new customers and seeing existing customers move through clinical phases. Acquisitions have added significantly to the TAM and provided multiple leverage opportunities, especially ...
S&P Global reports several changes to its stock market indices, highlighted by Bio-Techne's (NASDAQ:TECH) addition to the S&P 500, where it will replace Maxim Integrated (NASDAQ:MXIM); Bio-Techne +0.5% following the news. Joining the S&P Midcap 400 are Saia (NASDAQ:SAIA)...
Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600 Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600...
BioLife Solutions, Inc. (BLFS) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET Company Participants Roderick de Greef – Chief Financial Officer Mike Rice – Chairman and Chief Executive Officer Dusty Tenney – President and Chief Operating Officer Conference Cal...
Image source: The Motley Fool. BioLife Solutions, inc (NASDAQ: BLFS) Q2 2021 Earnings Call Aug 12, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: BioLife Solutions, inc (BLFS) Q2 2021 Earnings Call Transcript
BioLife Solutions Announces Second Quarter 2021 Financial Results Total revenue grew 215% over Q2 2020 and 85% over Q1 2021 Organic revenue up 49% over Q2 2020 driven by 45% media revenue growth Full year revenue guidance raised to $108 to $117 million, reflecting expect...
Sexton Biotechnologies to be Acquired by Biolife Solutions Innovative tools provider for the cell and gene therapy industry to accelerate their journey creating tools for tomorrow's therapies PR Newswire INDIANAPOLIS , Aug. 9, 2021 /PRNewswire/ -- Sexton Bi...
BioLife Solutions to Acquire Sexton Biotechnologies to Expand Cell and Gene Therapy Tools Portfolio Sexton's Proprietary Consumables and Media Products are Embedded in More than 50 Ongoing Cell Therapy Clinical Trials Sexton Expected to Contribute Approximately $8 Million in...
BioLife Solutions to Report Second Quarter 2021 Financial Results and Provide Business Update on August 12, 2021 PR Newswire BOTHELL, Wash. , Aug. 5, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading ...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...